Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials

BMJ 2017;358:j3927

This systematic review and meta-analyses of relapse prevention trials aims to examine the risk of relapse and time to relapse after discontinuation of antidepressants in patients with anxiety disorder who responded to antidepressants, and to explore whether relapse risk is related to type of anxiety disorder, type of antidepressant, mode of discontinuation, duration of treatment and follow-up, comorbidity, and allowance of psychotherapy.

Click here to view the full text paper.

Advertisements

Journal of Psychiatric Research – November 2017

The November edition of Journal of Psychiatric Research has been published.  This issue includes papers on findings from the CO-MED trial: Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response and predictors of rapid high weight gain in schizophrenia.

Click here to view the table of contents.

Click here to request an article from the Library.

Making sense of social prescribing

Social Prescribing Network, September 2017

This document provides an overview of various aspects of social prescribing such as: What is social prescribing; why do social prescribing; what do different models look like; what makes a good link worker; what makes a good referral; governance and risk management; evaluation.

Click here to view the document.

Study Skills Reading List

Lancashire Care Library and Information Service, September 2017

Are you starting a new course this September?  Has it been a while since you did any studying or wrote an essay?  Have a look at the new reading topic for Study Skills which will point you in the direction of useful books and resources to help you develop your skills.

Click here to view the Study Skills Reading Topic.

Spotlight on specialised services

NHS England, September 2017

This report provides an insight into some of the life-transforming specialised services in the NHS that are already being delivered and will continue to be rolled out over the coming years.  This includes the availability of a new drug, rituximab, to target a newly classified autoimmune disease and expanded perinatal mental health inpatient services.

Click here to view the full report.

 

Leading Large Scale Change

NHS England, September 2017

NHS England have produced a guide to leading large scale change to help all those involved in seeking to achieve transformational change in complex health and care environments. It is relevant to all those involved in transformational change programmes such as Sustainability and Transformation Partnerships (STPs) and the development of new care models, and has relevance across public services.

Click here to access the guide and executive summary.